Cytodyn Inc (CYDY)

[gestalt2]

I might have a naive view of this but the FDA's job is to evaluate if a drug does what the developer says it does and is safe. there are many treatments that have a long list of side effects, possible safety issues, may only work for a very limited # of people and only improve their health only slightly that are FDA approved. The drugs that fail to get FDA approval have patients who die and or drop out due to side effects in trials and/or the drug ends up not working in its intended benefit. We don't have those problems at this point, to think that The FDA is some sort of gatekeeper that just decides to limit the application of a drug or not approve without good reason does not seem to be true. If anything the FDA looks to me to want the trials to go well and approve without any issues. I don't know if the FDA will just widen the label but i surely don't think they are holding pro 140 back in any way. The FDA does not care about a stock price or the competition to a drug - they are not doing market analysis as a determining factor on FDA approval.